Academic society to retract push for eugenic protection law 66 yrs after its proposal
By Norikazu Chiba,
The Mainichi
| 12. 19. 2018
TOKYO -- The Japanese Society for Hygiene, which was active in promoting eugenic policies under the now-defunct eugenic protection law, has decided to retract its proposal made 66 years ago to the government for the use of forced sterilization operations as a means of population control, judging that the move was discriminatory.
It will be the first official admission of a mistake by an academic society among several, such as those for psychiatric medicine or social sciences, which supported sterilization operations against people with mental or physical disabilities that were deemed very serious or hereditary. As many as 25,000 people are believed to have received such surgeries under the 1948-1996 law that is now deemed inhuman, and multiple political parties are putting together a plan to compensate those victims.
Chairman Takemi Otsuki of the society, who also serves as professor of hygiene at Kawasaki Medical School, explains that the society reached the decision as measures have been taken to support the victims of forced sterilization operations. "We want to play a new role to stem the decline in the number...
Related Articles
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Jay S. Kaufman, Los Angeles Review of Books | 09.27.2025
This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...